Cargando…

Characterization of Metabolic Parameters in Responders and Nonresponders Treated with Canagliflozin Monotherapy in Drug-naive Subjects with Type 2 Diabetes

OBJECTIVES: The aim of this project is to compare the effect of canagliflozin monotherapy on metabolic parameters between responders and nonresponders with this drug. This study is a prospective, unblinded, observational study. SUBJECTS AND METHODS: Drug-naïve patients with type 2 diabetes mellitus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kutoh, Eiji, Wada, Asuka, Murayama, Teruma, Hayashi, Jyunka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972471/ https://www.ncbi.nlm.nih.gov/pubmed/29911028 http://dx.doi.org/10.4103/ijem.IJEM_578_17

Ejemplares similares

Two Glucose-Lowering Mechanisms of Canagliflozin Depending on Body Weight Changes in Drug-Naïve Subjects with Type 2 Diabetes
por: Kutoh, Eiji, et al.
Publicado: (2018)

Canagliflozin as an Initial Therapy in Drug-Naïve Subjects with Type 2 Diabetes Mellitus: A Potential Involvement of Atherogenic Lipids in its Glycemic Efficacy
por: Kutoh, Eiji, et al.
Publicado: (2017)

Distinct Glucose-Lowering Mechanisms of Ipragliflozin Depending on Body Weight Changes
por: Kutoh, Eiji, et al.
Publicado: (2016)

Teneligliptin As an Initial Therapy for Newly Diagnosed, Drug Naive Subjects With Type 2 Diabetes
por: Kutoh, Eiji, et al.
Publicado: (2014)

Haplotype Analysis of GSK-3β Gene Polymorphisms in Bipolar Disorder Lithium Responders and Nonresponders
por: Iwahashi, Kazuhiko, et al.
Publicado: (2014)

Efficacy of Telmisartan Plus Amlodipine in Nonresponders to CCB Monotherapy
por: Neldam, Steen, et al.
Publicado: (2013)

Identifying responders and nonresponders to interferon therapy in multiple sclerosis
por: Prosperini, Luca, et al.
Publicado: (2014)

IGF and IGFBP as an index for discrimination between vitamin D supplementation responders and nonresponders in overweight Saudi subjects
por: Al-Daghri, Nasser M., et al.
Publicado: (2018)

Neurocognition and Subjective Experience Following Acute Doses of the Synthetic Cannabinoid JWH-018: Responders Versus Nonresponders
por: Theunissen, Eef L., et al.
Publicado: (2019)

Short‐term GAA loading: Responders versus nonresponders analysis
por: Ostojic, Sergej M.
Publicado: (2020)

Adaptive differentiation of murine lymphocytes. IV. (Responder × Nonresponder) F(1) T cells can be taught to preferentially help nonresponder,rather than responder, B cells
por: Katz, DH, et al.
Publicado: (1979)

Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise
por: Stenlöf, K, et al.
Publicado: (2013)

Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-β
por: Bustamante, Marta F., et al.
Publicado: (2015)

Molecular discrimination of responders and nonresponders to anti-TNFalpha therapy in rheumatoid arthritis by etanercept
por: Koczan, Dirk, et al.
Publicado: (2008)

Cost-effectiveness of early responders versus early nonresponders to atypical antipsychotic therapy
por: Peng, Xiaomei, et al.
Publicado: (2011)

Responders and nonresponders to topical capsaicin display distinct temporal summation of pain profiles
por: Wong, Felyx, et al.
Publicado: (2023)

An abnormality in glucocorticoid receptor expression differentiates steroid responders from nonresponders in keloid disease
por: Rutkowski, D., et al.
Publicado: (2015)

Low intensity extracorporeal shockwave Therapy shifts PDE5i nonresponders to responders
por: Wang, Jiamin, et al.
Publicado: (2020)

Self-Reported Complications after Tonsillectomy: Comparison of Responders and Nonresponders to a Mailed Questionnaire
por: Haye, Rolf, et al.
Publicado: (2020)

Linking Federal Administrative Records to Respondents and Nonrespondents in Household Surveys: A Case Study
por: Sakshaug, Joseph, et al.
Publicado: (2017)

Effect of Combination Therapy of Canagliflozin Added to Teneligliptin Monotherapy in Japanese Subjects with Type 2 Diabetes Mellitus: A Retrospective Study
por: Fushimi, Yoshiro, et al.
Publicado: (2020)

Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode
por: Belzeaux, R, et al.
Publicado: (2012)

Practical Approaches to Treat ED in PDE5i Nonresponders
por: Cai, Zhonglin, et al.
Publicado: (2020)

Cell‐Based Therapies: The Nonresponder
por: Caplan, Arnold I.
Publicado: (2018)

Responder T cells depleted of alloreactive cells react to antigen presented on allogeneic macrophages from nonresponder strains
Publicado: (1981)

Psychological Distress in Responders and Nonresponders in a 5-year Follow-up Health Survey: The RIAS Study
por: Tsubota-Utsugi, Megumi, et al.
Publicado: (2022)

High-frequency rTMS in the treatment of depressive symptoms in schizophrenia: a neurophysiological profile of respondents and nonresponders
por: Kaleda, V., et al.
Publicado: (2022)

Sitagliptin is effective and safe as add-on to insulin in patients with absolute insulin deficiency: a case series
por: Kutoh, Eiji
Publicado: (2011)

THE BEHAVIOR OF HAPTEN-POLY-L-LYSINE CONJUGATES AS COMPLETE ANTIGENS IN GENETIC RESPONDER AND AS HAPTENS IN NONRESPONDER GUINEA PIGS
por: Green, Ira, et al.
Publicado: (1966)

Differential systemic gene expression profile in patients with diabetic macular edema: Responders versus nonresponders to standard treatment
por: Dabir, Supriya S, et al.
Publicado: (2014)

The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine
por: Silberstein, Stephen D., et al.
Publicado: (2020)

Distinctively different predictors for long‐term outcomes between responders and nonresponders who underwent cardiac resynchronization therapy
por: Yufu, Kunio, et al.
Publicado: (2020)

Efficacy of a Trial Oral Appliance in OSAS Management: A New Protocol to Recognize Responder/Nonresponder Patients
por: Segù, Marzia, et al.
Publicado: (2021)

Canagliflozin: Effects in overweight and obese subjects without diabetes mellitus
por: Bays, Harold E, et al.
Publicado: (2014)

Early cellular events in a systemic graft-vs.-host reaction. I. The migration of responding and nonresponding donor lymphocytes
Publicado: (1975)

COVID-19 morbidity decreases with tixagevimab–cilgavimab preexposure prophylaxis in kidney transplant recipient nonresponders or low-vaccine responders
por: Kaminski, Hannah, et al.
Publicado: (2022)

Immunosuppressive factor(s) extracted from lymphoid cells of nonresponder mice primed with L-glutamic acid60-L-alanine30-L- tyrosine10 (GAT) II. Cellular source and effect on responder and nonresponder mice
Publicado: (1977)

Severe hypercalcemia and hypernatremia in a patient treated with canagliflozin
por: Kaur, Arshpreet, et al.
Publicado: (2015)

Euglycemic Diabetic Ketoacidosis with Persistent Diuresis Treated with Canagliflozin
por: Adachi, Junichiro, et al.
Publicado: (2017)

GENETIC CONTROL OF IMMUNE RESPONSES IN VITRO : IV. CONDITIONS FOR COOPERATIVE INTERACTIONS BETWEEN NONRESPONDER PARENTAL B CELLS AND PRIMED (RESPONDER x NONRESPONDER) F(1) T CELLS IN THE DEVELOPMENT OF AN ANTIBODY RESPONSE UNDERIr GENE CONTROL IN VITRO
por: Benacerraf, Baruj, et al.
Publicado: (1974)

Cannot write session to /tmp/vufind_sessions/sess_ge7jdgbke7i4mfrs2ha937e684